Analysis finds additional clinical benefits of molnupiravir for nonhospitalized participants with COVID-19
A secondary analysis of the randomized controlled MOVe-OUT trial found additional clinical benefits of molnupiravir for nonhospitalized participants with mild to moderate COVID-19 and risk factors for progression to severe ...
Jun 6, 2022
0
7